Peripheral Neuritis Treatment Market

Peripheral Neuritis Treatment Market - Global Industry Analysis 2014 - 2018 and Opportunity Assessment; 2019 - 2029

Market Overview

This Peripheral Neuritis Treatment market study offers a comprehensive analysis of the business models, key strategies, and respective market shares of some of the most prominent players in this landscape. Along with an in-depth commentary on the key influencing factors, market statistics in terms of revenues, segment-wise data, region-wise data, and country-wise data are offered in the full study. This study is one of the most comprehensive documentation that captures all the facets of the evolving Peripheral Neuritis Treatment market.

Peripheral neuritis (peripheral neuropathy) is a conditions which damages peripheral nerves. Complications of peripheral neuritis affects motor, sensory and autonomic nerves control results into pain, muscle weakness, painful cramps and fasciculation. Currently peripheral neuritis treatment includes, surgery and noninvasive intervention such as transcutaneous electrical nerve stimulation (TENS) are being used to manage and treat symptoms associated with peripheral neuritis. Among all option for peripheral neuritis treatment, analgesics and local anesthetics are first line of treatment options to relieve symptoms of peripheral neuritis. Second line for peripheral neuritis treatment include antidepressants and anticonvulsants class of drugs. Choice of therapeutic agent in a class depends on severity of disease and symptoms of patients.

Peripheral Neuritis Treatment Market: Drivers and Restraints

Diabetes is the major cause of peripheral neuritis and expected to grow the global patient population affected by peripheral neuritis. Global peripheral neuritis treatment market is expected to grow owing to rising global epidemic of chronic diseases such as diabetes. Also, rigorous clinical research and development activities are estimated to fuel the future market opportunities. Increasing awareness of about treatment options is expected to drive growth of peripheral neuritis treatment market. Lack of awareness and poor healthcare infrastructure are key factor hampering the peripheral neuritis treatment market. Misdiagnosis is the major challenge owing to nature of complex symptoms of peripheral neuritis which may hamper market growth.

Peripheral Neuritis Treatment Market: Overview

The global peripheral neuritis treatment market is expected to grow with significant growth owing to increasing prevalence of peripheral neuritis. Anti-depressants and anticonvulsants are first line of treatment, hence these two segment collectively gains majority of revenue share for peripheral neuritis treatment market. In near future, biologicals can be emerging class in the global peripheral neuritis treatment market. Diabetes peripheral neuropathy is dominant segment by indication and expected to provide high growth opportunities over the forecast period. In recent developments, few players are focusing on development of biologicals instead of synthetic drugs to treat peripheral neuritis owing to their better efficacy and less safety concerns. Recently, Tarlige tablet a new product of Daiichi-Sankyo, Japan has been approved in Japan for peripheral neuropathic pain. Similarly, a startup Stimwave Technologies, USA has been launched a clinical study to investigate its wireless device to treat painful peripheral neuropathy.

Peripheral Neuritis Treatment Market: Regional Outlook

The global peripheral neuritis treatment market is expected to be dominated by the North America region owing to high prevalence of peripheral neuritis and availability of innovative therapeutics. Increasing prevalence of diabetes is the key reason behind the robust growth of peripheral neuritis treatment market in East Asia and South Asia. Europe and Oceania peripheral neuritis treatment markets are expected to grow at steady rate pertaining to increasing disease awareness and new products availability. In the global peripheral neuritis treatment market, Middle East & Africa is expected to be the least lucrative region owing to poor healthcare infrastructure and limited awareness about treatment.

Peripheral Neuritis Treatment Market: Key Players

The key players operating in the global complement-targeted therapeutics market are: Pfizer, Depomed Inc, Novartis, Biogen Idec, GlaxoSmithKline Plc, Sanofi SA, Eli Lilly and Company, Bristol-Myers Squibb, Baxter Healthcare Corporation, Johnson & Johnson, Teva Pharmaceuticals and others.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to market segments such as geographies, application, and industry.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to market segments such as geographies, application, and industry.

The report covers exhaust analysis on: 

  • Market Segments
  • Market Dynamics
  • Market Size
  • Supply & Demand
  • Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Indication
  • Value Chain
  • Parent Market Analysis

Regional analysis includes:

  • North America (U.S., Canada)
  • Latin America (Mexico, Brazil, Argentina)
  • Europe (Germany, Italy, France, U.K, Spain, Russia)
  • East Asia (China, Japan, South Korea)
  • South Asia (India, Indonesia, Thailand, Malaysia)
  • Oceania (Australia, New Zealand)
  • Middle East and Africa (GCC Countries, South Africa, Turkey, Northern Africa)

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Peripheral Neuritis Treatment Market: Segmentation

The global peripheral neuritis treatment market is segmented on the basis of drug class, indication, treatment type, distribution channel and region

Based on drug class, the global peripheral neuritis treatment market is segmented as:

  • Anti-Depressants
  • Tricyclic
  • Selective Serotonin/Norepinephrine Reuptake Inhibitors
  • Serotonin Reuptake Inhibitors
  • Anticonvulsants
  • Local Anesthesia
  • Analgesics
  • NSAID
  • Opioid
  • Steroids
  • Others
  • Others

Based on indication, the global peripheral neuritis treatment market is segmented as:

  • Diabetic peripheral neuropathy (DPN)
  • Chemotherapy-induced peripheral neuropathy (CIPN).
  • Idiopathic Peripheral Neuropathy (IPN)
  • Others

Based on the distribution channel, the global peripheral neuritis treatment market is segmented as:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Drug Stores
  • Online Pharmacies

Report Highlights:

  • Detailed overview of parent market
  • Changing market dynamics in the industry
  • In-depth market segmentation
  • Historical, current, and projected market size in terms of volume and value
  • Recent industry trends and developments
  • Competitive landscape
  • Strategies of key players and products offered
  • Potential and niche segments, geographical regions exhibiting promising growth

Need specific information?

In the news

How Businesses Can Utilize Market Research to Create Reactive, Recession-proof Strategies for Survival

by - Sudip Saha, Managing Director and Co-Founder of Future Market Insights

Our Clients

View Our Reports from Healthcare

View Reports

Recommendations

Peripheral Neuritis Treatment Market